Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04250558 · ClinicalTrials.gov registry record
ICG Fluorescence Imaging in Lower Extremity Amputation Patients
A clinical trial, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- 17
- Enrollment target
NCT04250558 is a clinical trial that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 17 participants.
The verdict
NCT04250558 has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- 17 participants
- Enrollment target
Study Summary
This is a non-randomized prospective study of 30 patients scheduled to undergo lower extremity amputation (below the knee, through the knee or above the knee) evaluating bone perfusion and viability using indocyanine green (ICG) fluorescence imaging at several steps during surgical procedure.
Interventions
- PROCEDURE Lower Extremity Amputation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2020-02-01 |
| Est. Completion | 2023-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04250558
The ClinicalTrials.gov registry entry for NCT04250558 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lower Extremity Amputation is the first listed.
NCT04250558 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04250558 about?
NCT04250558 is a clinical study titled "ICG Fluorescence Imaging in Lower Extremity Amputation Patients". This is a non-randomized prospective study of 30 patients scheduled to undergo lower extremity amputation (below the knee, through the knee or above the knee) evaluating bone perfusion and viability using indocyanine green (ICG) fluorescence imaging at several steps during surgical procedure.
What is the current status of trial NCT04250558?
This trial is currently completed. The enrollment target is 17 participants. The study started on 2020-02-01. Estimated completion is 2023-06-30.
What interventions are being tested in trial NCT04250558?
The interventions under investigation include: Lower Extremity Amputation (PROCEDURE).
Who is sponsoring clinical trial NCT04250558?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.